The notice of proposed rulemaking (NPRM) promises long-sought relief for historians, journalists, and biographers. For these groups, the goal will be to ensure that the proposed rules are enacted as currently written.
[This post has been cross-posted to the Petrie-Flom Center's Bill of Health, which is conducting an online NPRM Symposium.]
11 September 2015: See update at the bottom of this post.
Showing posts with label Beauchamp. Show all posts
Showing posts with label Beauchamp. Show all posts
Friday, September 4, 2015
NPRM: Freedom for Historians, If They Can Keep It
Posted by
Zachary M. Schrag
at
8:19 AM
Labels:
Beauchamp,
Belmont,
critical inquiry,
generalizable,
history,
NPRM,
oral history,
risk
0
comments
Sunday, February 10, 2013
Faden et al. Question Research-Treatment Distinction
Writing in a special report of the Hastings Center Report, a team of prominent ethicists and researchers "argue that conceptual, moral, and empirical problems surround the received view that we can and should draw sharp distinctions between clinical research and clinical practice." Yet they decline to detail the implications of any regulatory change for IRB review of medical research, much less research in the social sciences and humanities.
[Kass, Nancy E., Ruth R. Faden, Steven N. Goodman, Peter Pronovost, Sean Tunis, and Tom L. Beauchamp. "The Research-Treatment Distinction: A Problematic Approach for Determining Which Activities Should Have Ethical Oversight." Hastings Center Report 43, no. s1 (2013): S4–S15. doi:10.1002/hast.133. h/t Yashar Saghai]
[Kass, Nancy E., Ruth R. Faden, Steven N. Goodman, Peter Pronovost, Sean Tunis, and Tom L. Beauchamp. "The Research-Treatment Distinction: A Problematic Approach for Determining Which Activities Should Have Ethical Oversight." Hastings Center Report 43, no. s1 (2013): S4–S15. doi:10.1002/hast.133. h/t Yashar Saghai]
Posted by
Zachary M. Schrag
at
9:18 AM
Labels:
Beauchamp,
Belmont,
bioethics,
biomedical,
definitions,
generalizable
0
comments
Thursday, April 26, 2012
Beauchamp and Saghai on the Mystery of Generalizable Knowledge
Philosophers Tom L. Beauchamp and Yashar Saghai find that although never defined, "the criterion of generalizable knowledge . . . is the foundation stone of the [National] Commission's conceptual and moral scheme in Belmont and beyond.
[Tom Beauchamp and Yashar Saghai. "The Historical Foundations of the Research-Practice Distinction in Bioethics," Theoretical Medicine and Bioethics 33, no. 1 (2012): 45–56. DOI 10.1007/s11017-011-9207-8. h/t Nathan Emmerich.]
[Tom Beauchamp and Yashar Saghai. "The Historical Foundations of the Research-Practice Distinction in Bioethics," Theoretical Medicine and Bioethics 33, no. 1 (2012): 45–56. DOI 10.1007/s11017-011-9207-8. h/t Nathan Emmerich.]
Posted by
Zachary M. Schrag
at
12:11 PM
Labels:
Beauchamp,
congress,
generalizable,
history,
law
0
comments
Monday, April 4, 2011
Beauchamp Derides Federal Definition of Research
Along with Whitney and Schneider's article on the cost in lives of ethics board review of biomedical research, the "ethics symposium" in April 2011 issue of the Journal of Internal Medicine features an intriguing essay by Tom Beauchamp, Senior Research Scholar at the Kennedy Institute of Ethics and Professor of Philosophy at Georgetown University.
[T. L. Beauchamp, "Why Our Conceptions of Research and Practice May Not Serve the Best Interest of Patients and Subjects, Journal of Internal Medicine 269, no. 4, (April 2011): 383-387, doi: 10.1111/j.1365-2796.2011.02350_1.x]
As a staffer of the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research in the 1970s, Beauchamp played a key role in the development of the Belmont Report. Yet in this essay, he disparages one of the National Commission's most enduring legacies: the definition of research encoded in today's federal regulations.
[T. L. Beauchamp, "Why Our Conceptions of Research and Practice May Not Serve the Best Interest of Patients and Subjects, Journal of Internal Medicine 269, no. 4, (April 2011): 383-387, doi: 10.1111/j.1365-2796.2011.02350_1.x]
As a staffer of the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research in the 1970s, Beauchamp played a key role in the development of the Belmont Report. Yet in this essay, he disparages one of the National Commission's most enduring legacies: the definition of research encoded in today's federal regulations.
Posted by
Zachary M. Schrag
at
9:39 AM
Labels:
Beauchamp,
biomedical,
definitions,
generalizable,
OHRP,
regulations
2
comments
Subscribe to:
Posts (Atom)
